[New AMM: Nivolumab for advanced oesophageal squamous cell carcinomia after first line of chemotherapy].

[New AMM: Nivolumab for advanced oesophageal squamous cell carcinomia after first line of chemotherapy]. Bull Cancer. 2021 Jan 30;: Authors: Reich M, Coutzac C PMID: 33531154 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33531154?dopt=Abstract

Source: Bulletin du Cancer - January 30, 2021 Category: Cancer & Oncology Authors: Reich M, Coutzac C Tags: Bull Cancer Source Type: research